Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of opiranserin on quality of recovery in patients undergoing thyroid surgery
KCT0011928Phase 4Recruiting
- Sponsor
- Yonsei University Health System
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of opiranserin in thyroid neoplasm, sponsored by Yonsei University Health System. Started May 2026; status: recruiting.
02
Drugs
opiranserin
03
Conditions
thyroid neoplasm
Beyond the preview
Go deeper on KCT0011928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011928.